View Report Details
Global Molecular Diagnostics Market -------------------------------2012
View Report Details Executive Summary Human being has evolved with an unending quest for exploration. With constant research in medical and other sciences, molecular diagnostic tools and techniques were developed. Besides providing the medical work and a wider spectrum and accuracy of test findings, these tests have also enabled researchers to establish new findings about human body which is proving a boon against the rising complexities of health care in the present world. The global market of molecular diagnostics has increased significantly in the recent past and is anticipated to expand invariably in the years to come. The market is projected to record a CAGR of approximately 13.1% for the period spanning 2012-2014.
Testing for established infectious diseases such as HPV, CT/GC, and hepatitis, among others, represents the largest market category in terms of revenue generation. However, with the realm of molecular diagnostic testing in cancer screening undergoing a major change, the Oncology segment of the market will witness significant expansion in the times to come, driving the overall market for molecular diagnostics. Geographically, the US is the largest regional market in worldwide molecular diagnostics industry, with Europe and Japan trailing behind the US. While, these regions will continue to dominate the molecular diagnostics landscape, the emerging regions are expected to experience the fastest growth. The global molecular diagnostics market is presently characterized by growth in large value mergers and acquisitions and shifting focus towards tailored therapy and personalized treatment, especially in the field of Oncology. Further, rising incidences of genetic diseases unfolds new opportunities for genetic testing in the molecular diagnostics market. Further, the ever escalating demand for better healthcare solutions, coupled with ageing world population and rising new incidences of cancer are governing the global molecular diagnostics market growth, taking it to new heights. However, the global molecular diagnostics marketplace continues to be plagued by challenges in the form of rising price pressures and growing regulatory hurdles. The intensely competitive and fragmented global molecular diagnostics market is mainly led by a few large players. Roche, Qiagen, Gen-Probe, Novartis, Cepheid, and Becton Dickinson, are among the top notch players in the industry. The current report analyzes the global molecular diagnostic market. It also presents a view of the various segments of the market. The report discusses the drivers and challenges prevailing in the molecular diagnostics industry. It presents the competitive conditions prevailing in the global molecular diagnostic market, along with the profiles of major players.
Global molecular diagnostics market witnessed steady growth in the past, across various segments and regions… Global Molecular Diagnostics Market: 2007-2011
The molecular diagnostics segment held approximately……..share of the global IVD market in 2011. Global IVD market is anticipated to grow steadily over a long term. The global market for molecular diagnostics was valued at about US$…….. billion in 2011, up by approximately ……% over the prior year. Furthermore, the market registered a CAGR of approximately …….% during 20072011. Global Molecular Diagnostics Market Breakdown by Regions (%): 2010
The major revenue generating regions of the global molecular diagnostics market are ……,………, and …………….., collectively accounting for ………..% share of the world market in 2010. Nearly………number of molecular diagnostics tests products were approved by the FDA in the US in 2010, of which approximately ………% were accounted by………….product category.
Segmental breakup of global molecular diagnostics market… Global Molecular Diagnostics Market Breakup by Segments (%): 2010
The global molecular diagnostics market can be largely categorized into five sub segments, with ………….segment accounting for a lion’s share of the overall market. The share of……….segment, nearly ……% as noted in 2010, is anticipated to witness fastest growth in the coming years, thus accounting for about ……..% share by the end of 2015.
The market for molecular diagnostics can be further categorized on the basis of application or types of diseases including ………, ………, ………, and …….., among others. Global Molecular HPV Testing Market: 2010-2013E
Global Molecular HPV testing market was worth US$......million in 2010, down by ……% over a year ago period. The US is the largest molecular HPV testing market, accounting for nearly US$……..million sales during the same period. The global CT/GC market was valued at about US$......million in 2011.
Long term growth expected in the global molecular diagnostics market supported by numerous factors… Global Molecular Diagnostic Market Share by Companies (%): 2011
• Roche is the leading player in the worldwide molecular diagnostics market, with a share of about……..% in 2011, immediately followed by………. and ……….. • The global molecular diagnostics market is projected to witness steady increase in the years to come, reaching approximately US$...........billion by the end of 2014. Global Molecular Diagnostics Market Forecast: 2010-2014F
• The factors responsible for steady and continuous increase in the molecular diagnostics market, world over, include ………………., ………………………., …………….., and ……………….., among others. •
The rising ………. and ……………testing market is expected to significantly drive the global molecular diagnostics market over a long tem.
View Report Details Table of Contents List of Charts and Tables 1. Overview
List of Charts
1.1 In Vitro Diagnostics: Industry Overview 1.2 Molecular diagnostics
IVD Market – Segments by Technology Molecular Diagnostcs – Traditional Process Main Purposes of Molecular Diagnostics Global In-Vitro Diagnostics Market Revenues, 2004-2010 Growth in Global In-Vitro Diagnostics Market, 2005-2016F Global IVD Market Classification by Segments, 2011 Global IVD Market by Regions, 2010 & 2015F Market Share of Leading Players in the Global IVD Market, 2010 Global Molecular Diagnostics Market, 2007-2011 Global Molecular Diagnostics Market Breakup by Segments, 2010 & 2015F Global Molecular Diagnostics Market Breakup by Application Areas, 2010 Global Molecular Diagnostics Market Breakdown by Regions, 2010 Number of Molecular Diagnostic Products Approved in the US, 2010 Global Molecular HPV Testing Market, 2010-2013E HPV Testing Market Penetration Rates in the US, 2010-2013E Global CT/GC Market Revenues, 2011 Global CT/GC Market Share by Leading Companies, 2011 The US Market for Influenza Diagnostic Tests, 2010 Current Standards of Care in Various Therapeutic Areas, 2011 Mergers & Acquisitions in Molecular Diagnostics Sector, 2008-2010 Number of Genetic Tests and Laboratories Available Worldwide, 19932011 Global Ageing Population, 2005-2013F Global Healthcare Spending, 2005-2010 Global Molecular Diagnostic Market Share by Companies, 2011 Leading Players in PCR Based Global Molecular Diagnostics Market, 2010 Roche’s Revenues by Business Segments, 2011 Roche’s Revenues and Net Income, 2007-2011 Novartis’ Revenues by Business Segments, 2011 Novartis’ Revenues and Net Income, 2007-2011
2. Global Market Structure 2.1 Global IVD Market 2.1.1 Global Market Size 2.1.2 Market Segmentation 2.1.3 Competitive Scenario in IVD Market 2.2 Global Molecular Diagnostics Market 2.2.1 Global Market Size 2.2.2 Market by Segments 2.2.3 Market by Regions 2.3 Molecular Diagnostics Segments Analysis 2.3.1 HPV 2.3.2 CT/GC 2.3.3 Influenza 3. Molecular Diagnostics - Market Dynamics 3.1 Trends & Developments 3.1.1 Molecular Diagnostics in Oncology: Focus on Personalized Treatment 3.1.2 Growing M&A Activity in the Molecular Diagnostics Landscape 3.1.3 Emerging Korean Molecular Diagnostics Busine 3.1.4 Growth in Genetic Testing 3.1.5 Development of Industry’s First Real-Time “Multiplex Quantification” Molecular Diagnostic Testing Technology
View Report Details 3.2 Growth Drivers 3.2.1 Growing Ageing Population 3.2.2 Rising Demand for Better Healthcare Options 3.2.3 Rise in Healthcare Spending
Qiagen’s Revenues Share by Source of Revenues, 2011 Qiagen’s Revenues and Net Income, 2007-2011 Gen-Probe’s Revenues Share by Source of Revenues, 2011 Qiagen’s Revenues and Net Income, 2007-2011 Global Molecular Diagnostics Market Forecast, 2010-2014F
3.3 Challenges
List of Tables
3.3.1 Increasing Safety Regulations 3..2 Escalating Price Pressure
Patients Worldwide Waiting for Better Treatment Options, 2011 Non-PCR Amplification Processes Global Peer Comparison in the Molecular Diagnostics Market, 2011 Global Molecular Diagnostic Companies – Proprietary Technology Dependent & Independent Variables, 2004-2010 Correlation Matrix Model Summary – Coefficient of Determination Regression Coefficients Output
4. Molecular Diagnostics - Competitive Scenario Competitive Overview Market Share Peer Comparison 5. Company Profiles 5.1 Roche Holdings AG Business Description Key Financials Business Strategies Focus On Innovative Diagnostics Leverage Expertise in Molecular Biology 5.2 Novartis AG Business Description Key Financials Business Strategies Sustained Investment in Innovation Expansion in High-Growth Markets
View Report Details 5.3 Qiagen N.V. Business Description Key Financials Business Strategies Complete Automation Systems Continuously Adding New Test Content 5.4 Gen-Probe Incorporated Business Description Key Financials Business Strategies Expanding Product Portfolio Market Expansion within Clinical Diagnostics 6. Market Outlook 6.1 Market Forecast 6.2 Forecast Methodology 6.2.1 Dependent and Independent Variables 6.2.2 Correlation Analysis 6.2.3 Regression Analysis
View Report Details
Contact Us:
These are abridged and sanitized sample pages from the comprehensive report on the “Global Molecular Diagnostics Market�. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com